We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Fetal Cell-Based NIPT Demonstrated by Droplet Digital PCR

By LabMedica International staff writers
Posted on 27 Feb 2020
Print article
Image: MACS Technology is a fast and gentle method for the isolation of viable and functionally active cells by magnetic labeling (Photo courtesy of University of Konstanz).
Image: MACS Technology is a fast and gentle method for the isolation of viable and functionally active cells by magnetic labeling (Photo courtesy of University of Konstanz).
Noninvasive testing techniques are often used for fetal diagnosis of genetic abnormalities, but are limited by certain characteristics, including non-informative results. Thus, novel methods of noninvasive definitive diagnosis of fetal genetic abnormalities are needed.

Most noninvasive prenatal diagnostic tests (NIPT) on DNA today analyze cell-free fetal DNA, which is mixed in with large amounts of maternal cell-free DNA in the mother's blood. However, it has long been known that a very small number of fetal or placental cells, estimated at fewer than 10/mL, circulate in the blood of pregnant women.

Scientists at the National Research Institute for Child Health and Development (Tokyo, Japan) recruited 32 pregnant women without any obstetrical complications or abnormalities and malformations as determined by fetal ultrasonography at 20 weeks of gestation. Peripheral blood was obtained from each pregnant woman and non-nucleated cells were removed.

The washed nucleated blood cells were mixed with 10 μL each of CD45 microbeads and CD14 microbeads (Miltenyi Biotech GmbH, Bergisch Gladbach, Germany) and incubated for 15 minutes at 4 °C. The CD45–CD14– cell fraction was collected, white blood cells and large cells were removed to align the cell size, and cells were washed twice. The cells sorted by magnetic-activated cell sorting (MACS) were resuspended, processed and the stained cells were observed using the Axio Imager 2 fluorescence microscope system (Carl Zeiss Microscopy, Jena, Germany).

Single-cell–based droplet digital polymerase chain reaction (sc-ddPCR) was performed and after using the QX200 Droplet Generator, the PCR was subsequently analyzed with the signal of each droplet using the QX200 Droplet Reader (Bio-Rad, Hercules, CA, USA). DNA was extracted from each of the cell suspensions or umbilical cord blood samples. The team performed genetic confirmation of circulating male fetal cells in the CD45–CD14– cell fraction. The team used one reference probe, RPP30, and one Y-chromosome-specific probe for the SRY gene. One advantage of using that system is that it can analyze up to 3,000 individual cells per well.

The team’s modification of the sc-ddPCR system enabled the assessment of rare circulating fetal cells in the peripheral blood samples of pregnant women carrying male fetuses. However, the observation of more RPP30+SRY+ droplets in each sample was expected because two to six circulating fetal cells had been contained in 1 mL of maternal blood. When they applied their test to cell fractions from 13 maternal peripheral blood samples, they found that it correctly called only the three samples from women with a male fetus as SRY-positive and all 10 samples from women with a female fetus as SRY-negative.

The authors concluded that they had demonstrated that the modified sc-ddPCR system was able to effectively assess the genomic DNA of each targeted cell in a crudely sorted biological sample. This system is unprecedented in that the DNA of numerous individual live cells can be simply analyzed with high sensitivity and specificity without any whole-genome amplification, cell-fixation, and cell-staining steps. Moreover, this study serves as a proof of concept for noninvasive prenatal definitive diagnosis with extremely rare circulating fetal cells using our modified sc-ddPCR system. The study was published in the February 2020 issue of the Journal of Molecular Diagnostics.

Related Links:
National Research Institute for Child Health and Development
Miltenyi Biotech GmbH
Carl Zeiss Microscopy
Bio-Rad


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.